3 ms·
"patients' copayments for the drug could cost around $11,500 annually." For drugs like this the drug company pays the patients' total out of pocket (co-payment
by datavirtue 5y ago
"patients' copayments for the drug could cost around $11,500 annually."
For drugs like this the drug company pays the patients' total out of pocket (co-payment) in full on the first infusion. The patient never has anything to pay in this case...if they have insurance.
- whoknowswhat11 5y agoThis is actually how they manipulate / overcharge on pricing. Because the person paying is not the person getting, they can charge anything, and there is HUGE pressure to proscribe still. If instead they even required patients to still cover out of pocket portion, prices would need to be way lower. You see this overseas. People pay out of pocket. I was in a fair number of developing countries, it's actually a bit nuts for westerners. The process to get for example things like basic antibiotics is near over the counter. Other items are INSANELY cheap. And accessibility (if you have USD) is good.
- rootbear 5y agoMy sister, who is on Medicare, is paying over USD 10,000 a year for her cancer drugs (ALK-positive lung cancer). That's out of her pocket.
- mcguire 5y agoWhat are "drugs like this", and why is the drug company paying for it?